Search

Your search keyword '"Stefano Barbi"' showing total 53 results

Search Constraints

Start Over You searched for: Author "Stefano Barbi" Remove constraint Author: "Stefano Barbi"
53 results on '"Stefano Barbi"'

Search Results

1. Reporting tumor molecular heterogeneity in histopathological diagnosis.

2. Low Expression of ARHI Is Associated with Shorter Progression-Free Survival in Pancreatic Endocrine Tumors

3. Mutational profiling of kinases in human tumours of pancreatic origin identifies candidate cancer genes in ductal and ampulla of vater carcinomas.

4. Supplementary Table 3 from A Cross-Species Analysis in Pancreatic Neuroendocrine Tumors Reveals Molecular Subtypes with Distinctive Clinical, Metastatic, Developmental, and Metabolic Characteristics

5. Supplementary Methods, Figure Legends, Table Legends from A Cross-Species Analysis in Pancreatic Neuroendocrine Tumors Reveals Molecular Subtypes with Distinctive Clinical, Metastatic, Developmental, and Metabolic Characteristics

6. Supplementary Table 1 from A Cross-Species Analysis in Pancreatic Neuroendocrine Tumors Reveals Molecular Subtypes with Distinctive Clinical, Metastatic, Developmental, and Metabolic Characteristics

7. Supplementary Figures 1 - 6 from A Cross-Species Analysis in Pancreatic Neuroendocrine Tumors Reveals Molecular Subtypes with Distinctive Clinical, Metastatic, Developmental, and Metabolic Characteristics

8. Supplementary Table 2 from A Cross-Species Analysis in Pancreatic Neuroendocrine Tumors Reveals Molecular Subtypes with Distinctive Clinical, Metastatic, Developmental, and Metabolic Characteristics

9. Landscape of Druggable Molecular Pathways Downstream of Genomic CDH1/Cadherin-1 Alterations in Gastric Cancer

11. Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples

12. Molecular alterations associated with metastases of solid pseudopapillary neoplasms of the pancreas

13. MYC-related microRNAs signatures in non-Hodgkin B-cell lymphomas and their relationships with core cellular pathways

14. MAP Kinase inhibition reshapes tumor microenvironment of mouse pancreatic cancer by depleting anti-inflammatory macrophages

15. Gene expression profiling of lung atypical carcinoids and large cell neuroendocrine carcinomas identifies three transcriptomic subtypes with specific genomic alterations

16. Lung neuroendocrine tumours: deep sequencing of the four World Health Organization histotypes reveals chromatin-remodelling genes as major players and a prognostic role forTERT,RB1,MEN1andKMT2D

17. Whole-exome sequencing of duodenal neuroendocrine tumors in patients with neurofibromatosis type 1

18. MicroRNA signatures and Foxp3+cell count correlate with relapse occurrence in follicular lymphoma

19. Antimicrobial, antioxidant, and sun protection potential of the isolated compounds from Spermacoce princeae (K. Schum)

20. Photonic THz mixers based on iron-doped InGaAs embedded in a plasmonic microcavity

21. Identification of microRNAs implicated in the late differentiation stages of normal B cells suggests a central role for miRNA targets ZEB1 and TP53

22. Perihilar and distal extrahepatic cholangiocarcinomas show different genetic profiles but share MYC copy gain and TP53 mutation as independent poor prognostic markers

23. RASSF1 tumor suppressor gene in pancreatic ductal adenocarcinoma: correlation of expression, chromosomal status and epigenetic changes

24. Chromosome 3p alterations in pancreatic endocrine neoplasia

25. MEN1 in pancreatic endocrine tumors: analysis of gene and protein status in 169 sporadic neoplasms reveals alterations in the vast majority of cases

26. Signal transduction pathways of mantle cell lymphoma: A phosphoproteome-based study

27. A Cross-Species Analysis in Pancreatic Neuroendocrine Tumors Reveals Molecular Subtypes with Distinctive Clinical, Metastatic, Developmental, and Metabolic Characteristics

28. Molecular Biology of Neuroendocrine Tumors

29. Family history of gastric cancer: a correlation between epidemiologic findings and clinical data

30. Gene expression profiling after treatment with the histone deacetylase inhibitor trichostatin A reveals altered expression of both pro- and anti-apoptotic genes in pancreatic adenocarcinoma cells

31. Erratum: Corrigendum: Whole-genome landscape of pancreatic neuroendocrine tumours

32. Reporting tumor molecular heterogeneity in histopathological diagnosis

33. Mantle cell lymphoma cell lines show no evident immunoglobulin heavy chain stereotypy but frequent light chain stereotypy

34. A clinical-biological risk stratification model for resected gastric cancer: prognostic impact of Her2, Fhit, and APC expression status

35. Elevated urinary levels of urokinase-type plasminogen activator receptor (uPAR) in pancreatic ductal adenocarcinoma identify a clinically high-risk group

36. Phospho-proteomic analysis of mantle cell lymphoma cells suggests a pro-survival role of B-cell receptor signaling

37. Pancreatic endocrine tumors: expression profiling evidences a role for Akt-mTOR pathway

38. Anti-viral state segregates two molecular phenotypes of pancreatic adenocarcinoma: potential relevance for adenoviral gene therapy

39. The analysis of PIK3CA mutations in gastric carcinoma and metanalysis of literature suggest that exon-selectivity is a signature of cancer type

40. Mutational profiling of kinases in human tumours of pancreatic origin identifies candidate cancer genes in ductal and ampulla of vater carcinomas

41. An integrated humoral and cellular response is elicited in pancreatic cancer by alpha-enolase, a novel pancreatic ductal adenocarcinoma-associated antigen

42. Microsatellite instability in gastric cancer is associated with better prognosis only in stage II cancers

43. Loss of Fhit expression is associated with poorer survival in gastric cancer but is not an independent prognostic marker

44. Optically Pumped Terahertz Molecular Laser: Gain Factor and Validation up to 5.5 THz

45. Primary mediastinal B-cell lymphoma: hypermutation of the BCL6 gene targets motifs different from those in diffuse large B-cell and follicular lymphomas

46. Inhaled nitric oxide protects transgenic SAD mice from sickle cell disease-specific lung injury induced by hypoxia/reoxygenation

47. Autoantibodies to Ezrin are an early sign of pancreatic cancer in humans and in genetically engineered mouse models

48. TH-302 + Gemcitabine (G + T) vs Gemcitabine (G) in Patients with Previously Untreated advanced Pancreatic Cancer (PAC)

49. Prognostic impact of FHIT, APC, and HER2 status in resected gastric cancer: A clinical-biological risk stratification model

50. Mosaicking Weather Radar Retrievals from an Operational Heterogeneous Network at C and X Band for Precipitation Monitoring in Italian Central Apennines

Catalog

Books, media, physical & digital resources